Skip to main content

Karen D. Corbin, PhD, RD

Karen D. Corbin , PhD, RD

Associate Investigator

Translational Research

Karen D. Corbin

Overview

Dr. Corbin is an Associate Investigator at the AdventHealth Translational Research Institute. Her program of research focuses on nutrition and metabolism. She studies mechanisms, particularly the gut microbiome, that drive individual susceptibility to metabolic diseases such as obesity, diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD). Dr. Corbin’s research portfolio includes both investigator-initiated and industry clinical-translational studies focused on novel pathogenic mechanisms and therapeutics. Her ultimate goal is to advance clinically relevant research that is poised to transform patient care.

Dr. Corbin came to the TRI-MD after a 3-year term as a Research Assistant Professor at UNC Chapel Hill, Gillings School of Global Public Health, Department of Nutrition. This was preceded by her postdoctoral training also at UNC Chapel Hill. Dr. Corbin earned her doctorate degree in molecular medicine at the University of South Florida College of Medicine in 2008. She became a registered dietitian in 1998 after completing her dietetic internship at the James A. Haley Veteran’s Hospital in Tampa, FL. She earned her Bachelor’s Degree in Nutrition and Food Science in 1997 at Florida State University.

Articles

Associations of Skeletal Muscle Mass, Muscle Fat Infiltration, Mitochondrial Energetics, and Cardiorespiratory Fitness With Liver Fat Among Older Adults

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

2024

Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or Obesity

JOURNAL OF NUTRITION

2023

Measurement of 24-h continuous human CH4 release in a whole room indirect calorimeter

JOURNAL OF APPLIED PHYSIOLOGY

2023

Extracellular vesicle proteomics and phosphoproteomics identify pathways for increased risk in patients hospitalized with COVID-19 and type 2 diabetes mellitus

DIABETES RESEARCH AND CLINICAL PRACTICE

2023

Glucagon-like peptide-1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial

Obesity

2023

The proteome and phosphoproteome of circulating extracellular vesicle-enriched preparations are associated with characteristic clinical features in type 1 diabetes

FRONTIERS IN ENDOCRINOLOGY

2023

Host-diet-gut microbiome interactions influence human energy balance: a randomized clinical trial

NATURE COMMUNICATIONS

2023

An Overview of Diet and Physical Activity for Healthy Weight in Adolescents and Young Adults with Type 1 Diabetes: Lessons Learned from the ACT1ON Consortium

NUTRIENTS

2023

Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study*

JOURNAL OF DIABETES AND ITS COMPLICATIONS

2023

Associations of disordered eating with the intestinal microbiota and short-chain fatty acids among young adults with type 1 diabetes

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

2023

Education & Training

Education

University of South Florida College of Medicine

Fellowship

James A. Haley Veteran's Hospital, Tampa, FL

Associated Clinical Trials